U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942793) titled 'A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients' on April 16.
Brief Summary: This is a phase III, multicenter, randomized, double-masked, Active-controlled design. The aims to confirm previous findings of the efficacy and safety of CsA-PG Ophthalmic Gel by comparing it to CsA Ophthalmic Gel for treating dry eye symptoms.
Study Start Date: May 20
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease
Intervention:
DRUG: CsA-PG Ophthalmic Gel
Administer to eyes
DRUG: CsA Ophthalmic Gel
Administer to eyes
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Zhaoke (Guangzhou...